Acurastem Receives Target ALS Grant For ALS Therapeutics
10 Mar 2026 //
PR NEWSWIRE BIO
AcuraStem Welcomes Dr. Marcel van as Chief Scientific Officer
05 Dec 2024 //
PR NEWSWIRE
AcuraStem Enters into Agreement with Takeda to Advance PIKFYVE Therapeutics
26 Sep 2023 //
PR NEWSWIRE

Market Place
Sourcing Support